Insmed Inc. buy JPMorgan Chase & Co.
Start price
29.05.24
/
50%
€43.00
Target price
29.05.25
€50.69
Performance (%)
43.02%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. The BUY prediction by JPMorgan_Chase___Co_ for Insmed Inc. saw massive gains of 43.02%. JPMorgan_Chase___Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 1.587% | 1.587% | 79.021% |
| iShares Core DAX® | -5,87 % | -2,50 % | 2,29 % |
| iShares Nasdaq 100 | 1,66 % | 3,51 % | 13,19 % |
| iShares Nikkei 225® | -6,13 % | 2,14 % | 27,67 % |
| iShares S&P 500 | 0,50 % | 2,05 % | 9,82 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $36.00 to $55.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten